Participations à des congrès et colloques internationaux (104)

  1. 8. Bendoumou, M., Ait-Ammar, A., Nestola, L., & Van Lint, C. (2024). Identification of a new role for the E3-ubiquitin ligase activity of UHRF1 promoting HIV-1 transcriptional silencing. Poster présenté à la conférence Journées Francophones de Virologie (10 au 12 avril 2024: Université Libre de Bruxelles, Bruxelles, Belgique).
  2. 9. Santangelo, M., Bendoumou, M., Nestola, L., Renard, P., Dieu, M., & Van Lint, C. (2023). Identification of the cellular transcription factor KLF16 as a novel HIV-1 silencing factor. Poster présenté à la conférence Strategies for an HIV cure 2023 (October 12-13, 2023: National Institute of Allergy and Infectious Diseases (NIH)).
  3. 10. Marray, T., Hernalsteens, O., Verdikt, R., Vanhulle, C., Dutilleul, A., Nestola, L., Stiernon, L., Cristinelli, S. S., Monceaux, V., Verhasselt, B., Galons, H., Ciuffi, A., Sáez-Cirión, A., Rohr, O., & Van Lint, C. (2023). Role of the pol gene enhancer in HIV-1 transcription and replication in myeloid infected cells. Abstract session presented at HIV Cure symposium 2023(9th: 11/09/23: University of Ghent - Auditorium Oehoe, Building E1, Coupure Links 653, Gent, Belgium)
  4. 11. Van Lint, C. (2023). Epigenetic mechanisms of HIV-1 latency: implications for innovative therapeutic strategies. Abstract session presented at The FEMS2023 Congress, the 10th FEMS Congress of European Microbiologists(July 9-13, 2023: Hambourg, Germany)
  5. 12. Plant, E., Vreux, L., Galais, M., Nestola, L., Bendoumou, M., Peloponese, J. M., & Van Lint, C. (2023). Identification of the cellular factor UHRF1 as a new epigenetic repressor of Human T-Lymphotropic Virus type 1 (HTLV-1) transcription. Abstract session presented at FEMS 2023(09-13/07/23: CCH - Congress Center Hamburg Hamburg, Germany)
  6. 13. Van Lint, C. (2023). Transcriptional mechanisms of HIV-1 latency: implications for innovative therapeutic strategies. Paper session presented at The 2023 Annual Meeting of the MDC ERASE-HIV (June 21th and 23rd, 2023: Emory University, Atlanta, Georgia, USA).
  7. 14. Vreux, L., Ait-Ammar, A., Plant, E., Peloponese, J. M., Vanhulle, C., Galais, M., Van Drielen, S., Greguor, L., & Van Lint, C. (2023). Role of the cellular factor BCL11b in the transcriptional regulation of HTLV-1 (Human T-cell Leukemia virus type 1). Poster présenté à la conférence Retroviruses (May 22 - May 27, 2023: Cold Spring Harbor Laboratory).
  8. 15. Marray, T., Hernalsteens, O., Verdikt, R., Stiernon, L., Vanhulle, C., Dutilleul, A., Azouz, A., Galons, H., Goriely, S., Sáez-Cirión, A., & Van Lint, C. (2022). Epigenetic profile induced by the lineage-determining transcription factor PU.1 in the intragenic enhancer of Human Immunodeficiency Virus type 1 (HIV-1). Abstract session presented at BELGIAN SOCIETY FOR VIROLOGY (BELVIR) 2022(10th: 22/12/2022: The Royal Academies for Science and the Arts Hertogstraat/Rue Ducale 1, Brussels)
  9. 16. Ait-Ammar, A., Bendoumou, M., Santangelo, M., Nestola, L., & Van Lint, C. (2022). Role of UHRF1 in HIV-1 transcriptional repression through epigenetic and non-epigenetic mechanisms. 10th International Workshop on HIV Persistence during Therapy. Abstract session presented at 10th International Workshop on HIV Persistence during Therapy(December 13th to 16th 2022: Miami, Florida, USA)
  10. 17. Van Lint, C. (2022). Novel role of UHRF1 in the epigenetic repression of the latent HIV-1. Paper session presented at 10th BREACH (Belgian Research AIDS&HIV Consortium) Symposium (2022-11-23: La Hulpe, Belgium).
  11. 18. Hernalsteens, O., Verdikt, R., Dutilleul, A., Vanhulle, C., Azouz, A., Galons, H., Goriely, S., Sáez-Cirión, A., & Van Lint, C. (2022). Role of the pol gene enhancer in HIV-1 transcription and replication in myeloid infected cells. Poster présenté à la conférence Epigenetics and epigenomics in health and disease (17-19 November 2022: Brussels).
  12. 19. Plant, E., Bellefroid, M., Rodari, A., Galais, M., Krijger, P., Nestola, L., Vos, E., Van Driessche, B., Vanhulle, C., Ait-Ammar, A., Ciuffi, A., De Laat, W., & Van Lint, C. (2022). Implication of the cellular factor CTCF in the regulation of Bovine Leukemia Virus latency and tridimensional chromatin organization. Poster présenté à la conférence Epigenetics and Epigenomics in Health and Disease (17-19 November 2022: Brussels).

  13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 Suivant >>